期刊文献+

闽南地区人群中HLA-B* 5801基因频率的分析 预览 被引量:2

Analysis of frequency of HLA-B * 5801 in population of Chinese Minnan region
在线阅读 下载PDF
收藏 分享 导出
摘要 目的:了解闽南地区人群中HLA-B*5801的基因频率,探讨筛查HLA-B*5801的必要性。方法:本研究选取闽南地区178名需服用别嘌呤醇的患者(痛风患者40例,高尿酸血症患者89例和痛风性关节炎患者49例)和100名健康人,从全血中提取DNA,采用实时荧光PCR技术(Real-time PCR)和碱基序列测序(SBT)技术对所有DNA样本进行测定。结果:通过检测发现有22%的患者及16%的健康人含有HLA-B*5801,在患者中HLA-B*5801的基因频率为0.13,在健康人中为0.09,PCR法与SBT法检测结果一致。结论:闽南地区人群中HLA-B*5801的基因频率较高,因此需服用别嘌呤醇的患者在服药前有必要进行HLA-B*5801的筛查。 Objective: To investigate the gene frequency of HLA-B* 5801 in the population of Chinese Minnan region. Methods: In this study, we enrolled 178 patients requiring allopurinol therapy( including 40 patients with gout,89 patients with hyperuricemia and 49 patients with gouty arthritis) and 100 healthy people. We isolated genomie DNA from their blood and screened for HLA-B * 5801 with both PCR and gene sequencing. Results: We found 22% patients and 16% healthy people with HLA-B * 5801. The frequencies of HLA-B * 5801 in patients and healthy people are 0. 13 and 0. 09, respectively. The results from PCR and gene sequencing were consistent. Conclusion: The frequency of HLA-B * 5801 in the population of Chinese Minnan region is relatively high. Therefore,it is necessary to screen for HLA-B * 5801 in allopurinol users before taking the medicine.
作者 李珣 何颖豪 黄朝阳 张加勤 逯晓辉 胡斌 宋秀宇 LI Xun , HE Ying-Hao , HUANG Chao- Yang , ZHANG Jia-Qin , L U Xiao-Hui , HU Bin, SONG Xiu- Yu. (Department of Laboratory Medicine, The First Affiliated Hospital of Xiamen University and Teaching Hospital of Fujian Medical Uni- versity ,Xiamen 361003, China)
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2015年第5期663-666,共4页 Chinese Journal of Immunology
基金 本文受国家自然科学基金(81302529)、福建省自然科学基金(2014D007)资助.
关键词 闽南地区 HLA-B*5801 基因频率 Chinese Minnan region HLA-B * 5801 Gene frequency
作者简介 李珣(1982年-),男,博士,主管技师,助理教授,主要从事分子免疫与实验诊断研究,E-mail:lixxmcn@126.com. 通讯作者及指导教师:宋秀宇(1963年-),女,博士,主任技师,教授,硕士生导师,主要从事分子免疫与实验诊断研究,E—mml:songxyxm@hotmail.com。
  • 相关文献

参考文献8

  • 1王青,梅虎,张亚兰,潘显超,谭文,晁丽.遗传异质性药物毒副作用与HLA基因关联及分子机制研究进展[J].药学学报,2013,48(6):799-808. 被引量:1
  • 2Hung SI, Chung WH, Liou LB, et al. HLA-B * 5801 allele as a genetic marker for severe cutaneous adverse reactions caused by al- lopurinol E J ]. Proc Natl Acad Sci USA ,2005,102:4134-4319. 被引量:1
  • 3Chiu ml,Hu M,Ng MH,et al. Association between HLA-B * 58: 01 allele and severe cutaneous adverse reactions with allopurinol in Han Chinese in Hang Kong [J]. Br J Dermatol,2012,167:44-49. 被引量:1
  • 4Lee MH, Stocker SL, Williams KM,et al. HLA-B * 5801 should be used to screen for risk of Stevens-Johnson syndrome in family members of Han Chinesepatients commencing allopurinol therapy [ J]. J Rheumato1,2013 ,40 :96-97. 被引量:1
  • 5Lonjou C,Borot N,Sekula P,et ul. A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs [ J]. Pbermacogenet Genomics, 2008, 18: 99-107. 被引量:1
  • 6Tohkin M, Kaniwa N, Saito Y, eta/. A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal neerolysis in Japanese patients [ J]. Phannacogenomics J,2013,13 ( 1 ) :60-69. 被引量:1
  • 7Tassaneeyakul W, Jantararoungtong T, Chen P, et al. Strong association between HLA-B* 5801 and aUopurinol-induced Stevens-Johnson syndrome and toxic epidermal neerolysis in a Thai population I J ]. Pharmaeogenet Genomics,2009 ,19 :704-709. 被引量:1
  • 8Kang HR,Jee YK,Kim YS ,et al. Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans [ J ]. Pharmacogenet Genomlcs ,2011,21:303-307. 被引量:1

二级参考文献98

  • 1Carrasco-Garrido P, de Andres LA, Barrera VH, et al. Trendsof adverse drug reactions related-hospitalizations in Spain(2001-2006) [J]. BMC Health Serv Res, 2010,10: 287. 被引量:1
  • 2Aronson JK, Ferner RE. Clarification of terminology in drugsafety [J]. Drug Saf, 2005, 28: 851-870. 被引量:1
  • 3Burton P, Clayton D, Cardon L, et al. Genome-wide associationstudy of 14,000 cases of seven common diseases and 3,000shared controls [J]. Nature, 2007, 447: 661 —678. 被引量:1
  • 4Bharadwaj M, Illing P, Theodossis A, et al. Drug hypersensitivityand human leukocyte antigens of the major histocompatibilitycomplex [J]. Annu Rev Pharmacol Toxicol, 2012, 52: 401 -431. 被引量:1
  • 5Mead S, Uphill J, Beck J, et al. Genome-wide associationstudy in multiple human prion diseases suggests genetic riskfactors additional to PRNP [J]. Hum Mol Genet, 2012, 21:1897-1906. 被引量:1
  • 6Shen Y, Nicoletti P, Floratos A, et al. Genome-wide associationstudy of serious blistering skin rash caused by drugs [J].Pharmacogenomics J, 2012, 12: 96-104. 被引量:1
  • 7Pichler WJ, Naisbitt DJ, Park BK. Immune pathomechanismof drug hypersensitivity reactions [J]. J Allergy Clin Immunol,2011, 127: S74-81. 被引量:1
  • 8Mallal S, Nolan D, Witt C, et al. Association betweenpresence of HLA-B*5701, HLA-DR7, and HLA-DQ3 andhypersensitivity to HIV-1 reverse-transcriptase inhibitorabacavir [J]. Lancet, 2002, 359: 727 -732. 被引量:1
  • 9Martin AM, Nolan D, Gaudieri S,et al. Predisposition toabacavir hypersensitivity conferred by HLA-B*5701 and ahaplotypic Hsp70-Hom variant [J]. Proc Natl Acad Sci USA,2004,101:4180-4185. 被引量:1
  • 10Phillips EJ, Wong GA, Kaul R, et al. Clinical andimmunogenetic correlates of abacavir hypersensitivity [J].AIDS, 2005, 19:979-981. 被引量:1

同被引文献9

引证文献2

二级引证文献8

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈